GO
Loading...

GlaxoSmithKline PLC

More

  • Delta and Apple are big market movers Wednesday, 23 Jul 2014 | 4:38 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:. Delta Air Lines Inc., up $1.47 to $39.15. GlaxoSmithKline Plc., down $3.18 to $50.04.

  • FDA approves Gilead Sciences drug for 3 cancers Wednesday, 23 Jul 2014 | 12:57 PM ET

    WASHINGTON— The Food and Drug Administration on Wednesday approved a new cancer drug from Gilead Sciences Inc. to treat three types of blood cancer. The FDA has approved three other drugs for the disease in the last year: Roche's Gazyva, Janssen Pharmaceutical's Imbruvica and GlaxoSmithKline's Arzerra.

  • LONDON, July 23- Britain's fraud office is working with authorities in China in a first for such Anglo-Chinese cooperation as it carries out its own investigation into alleged corruption at drugmaker GlaxoSmithKline.

  • LONDON, July 23- GlaxoSmithKline cut its 2014 earnings outlook after sales fell by a worse-than-expected 13 percent in the second quarter as its all-important lung drugs struggled in the United States and a strong pound took a bite out of growth.

  • GSK cuts earnings forecast after weak 2nd quarter Wednesday, 23 Jul 2014 | 9:28 AM ET

    LONDON— Drug maker GlaxoSmithKline has cut its full-year earnings expectations as it says its second-quarter profits were hit by currency moves and a fall in sales of its respiratory drugs. The company said Wednesday it expects 2014 earnings per share to be broadly similar to last year.

  • UPDATE 2-GSK warns on profits as weak lung drug sales hit Wednesday, 23 Jul 2014 | 9:12 AM ET

    LONDON, July 23- GlaxoSmithKline cut its 2014 earnings outlook after sales fell by a worse-than-expected 13 percent in the second quarter as its all-important lung drugs struggled in the United States and a strong pound took a bite out of growth.

  • LONDON, July 23- GlaxoSmithKline cut its 2014 outlook after sales fell by a worse-than-expected 13 percent in the second quarter as its all-important lung drugs struggled in the United States and a strong pound took a bite out of growth.

  • Weak lung drug sales and strong pound hit GlaxoSmithKline Wednesday, 23 Jul 2014 | 7:11 AM ET

    LONDON, July 23- GlaxoSmithKline's sales fell by a worse-than-expected 13 percent in the second quarter as its all-important lung drugs struggled in the United States and a strong pound took a bite out of growth.

  • GSK CEO: 'Very committed' to China despite probe Wednesday, 23 Jul 2014 | 6:59 AM ET

    GlaxoSmithKline's share price plunged immediately following the announcement of its second quarter results on Tuesday.

  • LONDON, July 22- European shares bounced back on Tuesday on some strong earnings reports and after signs of cooperation between Russia and other nations in investigating the shooting down of a Malaysian airliner over Ukraine.

  • European shares bounce back as Ukraine tension ease Tuesday, 22 Jul 2014 | 11:25 AM ET

    LONDON, July 22- European shares rose on Tuesday on some strong earnings reports and signs of improved cooperation from Ukraine's pro-Russian rebels over the Malaysian Airlines plane shot down four days ago.

  • LONDON/ MUMBAI, July 22- Indian generics firm Lupin, some U.S. drugmakers looking for a tax-saving deal in Europe and private equity funds are planning to bid for a range of older drugs being auctioned by GlaxoSmithKline, five sources familiar with the matter said.

  • *ARM Holdings surges after strong results. LONDON, July 22- European equities bounced back on Tuesday partly in response to signs of improved cooperation from Ukraine's pro-Russian rebels who have agreed to hand over the black boxes from the Malaysian plane downed in Ukraine last week.

  • Politics fade as earnings take over Friday, 18 Jul 2014 | 6:30 PM ET
    Espirito Santo International is the parent company of several institutions, including Banco Espirito Santo.

    Even as traders monitor the world's hot spots, corporate earnings news could be a positive for stocks in the week ahead.

  • POWRANNA, Australia, July 18- Thousands of Black Angus bulls snort steam gently into the frigid early morning air at Tasmania's largest cattle feedlot as they jostle for space at a long grain trough.

  • BEIJING, July 17- China will publicly prosecute a foreign couple linked to drugmaker GlaxoSmithKline Plc on charges of illegally obtaining private information, state media said. The announcement comes after the United States and Britain raised concerns about access to the trial.

  • BEIJING, July 17- China will try in public a foreign couple linked to drugmaker GlaxoSmithKline Plc on charges of illegally obtaining private information, state media said, after the United States and Britain raised concerns about access to the trial.

  • ZURICH, July 17- Swiss drugmaker Novartis posted a quarterly rise in sales that missed expectations and said it would focus on eking out gradual cost savings to boost margins as it prepares a radical business overhaul.

  • Novartis cites momentum in 3 percent profit rise Thursday, 17 Jul 2014 | 2:07 AM ET

    GENEVA— Swiss pharmaceutical company Novartis AG posted a 3 percent rise in second-quarter profits Thursday, reflecting what it described as solid growth and an increased focus on core products.

  • *Three ex-GSK staff seek labour arbitration in Shanghai. BEIJING/ SHANGHAI, July 16- Three former Chinese employees of GlaxoSmithKline PLC, which is embroiled in a long-running corruption probe in China, are seeking compensation for illegal dismissal from their jobs, a lawyer representing them told Reuters.